Loading Events

« All Events

10th Annual NGS & Clinical Diagnostics Congress

November 8 to 08:00 - November 9 to 17:00


CLICK HERE TO FIND OUT MORE

8-9 November 2018, London, UK

Oxford Global is proud to present its 10th Annual NGS & Clinical Diagnostics Congress taking place on 8-9 November 2018 in London. Part of the Genomics & Synthetic Biology Series UK, the Congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organizations as well as leading pharmaceutical and biotech companies.

Going into its 10th year, our NGS & Clinical Diagnostics Congress will feature over 90 case studies and presentations focused on the developments in NGS technologies, NGS data analysis as well as clinical applications & diagnostics of NGS.

Join Europe’s most successful Genomics Congress and take part in four events across the two days:

  • 10th Annual Next Generation Sequencing & Clinical Diagnostics Congress
  • 6th Annual Single Cell Analysis Congress
  • 4th Annual Genome Editing Congress
  • Synthetic Biology Congress

View the Agenda here>> https://bit.ly/2wG1mJN

Free Pre-Congress Live Webinar

Whole-Genome Sequencing for Precision Prostate Cancer Medicine
Hosted by Michael Fraser, Director, Prostate Cancer Program, Ontario Institute for Cancer Research
Register for free today: https://bit.ly/2ymKB7k

Can’t make the date? Register today and the recording of the webinar will be sent to you afterward.

For further information, prices & group discounts please contact d.dalby@oxfordglobal.co.uk

CLICK HERE TO FIND OUT MORE

Details

Start:
November 8 to 08:00
End:
November 9 to 17:00
Event Category:
Website:
https://www.oxfordglobal.co.uk/nextgenerationsequencing-congress/download-agenda/

Organizer

Oxford Global Conferences
Website:
http://www.oxfordglobal.co.uk/

Venue

Novotel London West
London, United Kingdom + Google Map

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.